Clinical Trial Update: Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide. [NA]

View source ↗

Summary

This entry describes a planned clinical trial investigating the pathogenesis of chronic kidney disease linked with metabolic dysfunction-associated fatty liver …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Metabolic Dysfunction-associated Fatty Liver Disease

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Chronic Kidney Diseases, MAFLD | NA | Status: NOT_YET_RECRUITING